On the contrary, inhibition of STAT3 can downregulate the expression of programmed cell death 1 ligand 1 (PD-L1) and enhance the infiltration of T cells into tumor tissues, exhibiting synergistic effect in combination with programmed cell death protein 1 (PD-1)/PD-L1 blockade [27,28]. Here, STAT3 is linked to neoplasm.